Replies to post #19231 on Pluristem Therapeutics Inc (PSTI)

[Auto1]

Still think we should have driven Preeclampsia through to the goal-line; don't you, Jack?

[Spideyboy]

This I agree with you on, it was mentioned that the finance aspect needs continued work and I'll be holding off more buys until we get closer. I assume though the financial aspect is why this who KOL panel day was devised.

They mentioned revenues from Chart and Thermo, and EAP for 2019, but doubt that will be able to cover the costs they'll have.

I know people here have a hard time relating to mentioned milestones and not without reason, for the big players it could be a good time to increase or start positions.